Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tricaprilin in Mild to Moderate Alzheimer's Disease Dementia
NCT05809908Phase 3Not yet recruiting
- Sponsor
- Cerecin
- Start
- Jul 2027
- Primary completion
- Jan 2030
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tricaprilin in Alzheimer's disease (AD), sponsored by Cerecin. Planned start Jul 2027; status: not yet recruiting.
02
Drugs
tricaprilin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05809908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05809908.